TP-434

· Tetraphase Pharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TP-434, covering 2015-09-04 to 2015-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections [Phase 2]